Evidence map›Paper›PMID 32833184›Full record

ArticleMolecular biology reports2020

Betaine effects against asthma-induced oxidative stress in the liver and kidney of mice.

Anahita Pourmehdi, Zahra Sakhaei, Masoud Alirezaei, Omid Dezfoulian

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Mechanisms ofBiology · 2025
    Article
  8. Article
  9. Article
  10. Anti-inflammatory and antioxidant properties of betaine protect against sepsis-induced acute lung injury: CT and histological evidence.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2023
    Article
  11. Review
  12. Plasma Metabolomic Profiling of Patients Recovered From Coronavirus Disease 2019 (COVID-19) With Pulmonary Sequelae 3 Months After Discharge.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Anahita PourmehdiUndergraduate Student of Veterinary Medicine, School of Veterinary Medicine, Lorestan University, P. O. Box: 465, Khorramabad, Iran.ORCID http://orcid.org/0000-0002-0505-0416
Zahra SakhaeiUndergraduate Student of Veterinary Medicine, School of Veterinary Medicine, Lorestan University, P. O. Box: 465, Khorramabad, Iran.ORCID http://orcid.org/0000-0002-2941-240X
Masoud AlirezaeiDivision of Biochemistry, School of Veterinary Medicine, Lorestan University, P. O. Box: 465, Khorramabad, Iran. alirezaei.m@lu.ac.ir.ORCID http://orcid.org/0000-0003-1022-8896
Omid DezfoulianDepartment of Pathobiology, School of Veterinary Medicine, Lorestan University, P. O. Box: 465, Khorramabad, Iran.ORCID http://orcid.org/0000-0002-1162-9248
Lorestan University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Allergic asthma is a chronic inflammatory airway disease concomitant with oxidative stress. The aim of this study was to evaluate the effects of betaine against asthma-induced oxidative stress in experimentally animal model. 32 BALB/C mice were divided into four equal groups as: control, asthma, prednisolone and betaine groups. 100 μl of the solution (Ova albumin (OVA, 400 μg and AL(OH)3 gel in 1 ml of phosphate buffer) was injected intraperitoneally to each mouse on days 0, 7, 14 and 21 and sensitized with OVA drop, three times a week from days 27 until 84 in asthma, prednisolone and betaine groups. Prednisolone (3 mg/kg) and betaine (1% of the total diet) were administered at day 27 to 84 as orally once daily and vehicle to controls and asthma group. Sera were collected for IgE detection and lung tissue was taken for histopathology assessment. Glutathione peroxidase (GPx), catalase (CAT), superoxide dismutase (SOD) activities, and glutathione content (GSH) as well as malondialdehyde (MDA) concentration as lipid peroxidation marker were also measured in the liver and kidney tissues. Pathological changes of the lung tissue were observed in the asthma and prednisolone groups. Prednisolone also caused significant increase level of anti-OVA IgE. The GPx activity increased significantly in the liver and kidney of asthmatic group when compared to the control and prednisolone groups. Liver MDA as lipid peroxidation marker was also significantly higher in the prednisolone-treated mice when compared to the other groups. Although the CAT and SOD activities as well as GSH content increased in the betaine and prednisolone-treated mice, these enhancements were not statically significant. Predinsolone as first choice in asthma treatment showed some oxidative properties. In contrast, betaine improved airway inflammation of lung tissue which may be associated with the antioxidant properties of betaine. This study provides a potential promising effect of betaine for treatment of asthma in future studies.

Indexed as

AnimalsAntioxidantsAsthmaBetaineDisease Models, AnimalFemaleGlucocorticoidsInflammationKidney DiseasesLipotropic AgentsLiver DiseasesMiceMice, Inbred BALB COxidative StressPrednisoloneAntioxidantsBetaineGlucocorticoidsLipotropic AgentsPrednisoloneAsthmaBetaineLungOxidative stressPrednisolone

Identifiers

PMID32833184
OpenAlexW3080896592

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.